391 related articles for article (PubMed ID: 30402465)
1. Status of Artemisinin Resistance in Malaria Parasite
Oboh MA; Ndiaye D; Antony HA; Badiane AS; Singh US; Ali NA; Bharti PK; Das A
Biomed Res Int; 2018; 2018():2305062. PubMed ID: 30402465
[TBL] [Abstract][Full Text] [Related]
2. Local emergence in Amazonia of
Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
Elife; 2020 May; 9():. PubMed ID: 32394893
[TBL] [Abstract][Full Text] [Related]
3. Absence of association between polymorphisms in the pfcoronin and pfk13 genes and the presence of Plasmodium falciparum parasites after treatment with artemisinin derivatives in Senegal.
Delandre O; Daffe SM; Gendrot M; Diallo MN; Madamet M; Kounta MB; Diop MN; Bercion R; Sow A; Ngom PM; Lo G; Benoit N; Amalvict R; Fonta I; Mosnier J; Diawara S; Wade KA; Fall M; Fall KB; Fall B; Pradines B
Int J Antimicrob Agents; 2020 Dec; 56(6):106190. PubMed ID: 33045351
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
Yaqoob A; Khattak AA; Nadeem MF; Fatima H; Mbambo G; Ouattara A; Adams M; Zeeshan N; Takala-Harrison S
Malar J; 2018 Dec; 17(1):471. PubMed ID: 30558587
[TBL] [Abstract][Full Text] [Related]
5. Absence of Plasmodium falciparum artemisinin resistance gene mutations eleven years after the adoption of artemisinin-based combination therapy in Nigeria.
Ikegbunam M; Ojo JA; Kokou K; Morikwe U; Nworu C; Uba C; Esimone C; Velavan TP; Ojurongbe O
Malar J; 2021 Nov; 20(1):434. PubMed ID: 34758836
[TBL] [Abstract][Full Text] [Related]
6. Role of Plasmodium falciparum Kelch 13 Protein Mutations in P. falciparum Populations from Northeastern Myanmar in Mediating Artemisinin Resistance.
Siddiqui FA; Boonhok R; Cabrera M; Mbenda HGN; Wang M; Min H; Liang X; Qin J; Zhu X; Miao J; Cao Y; Cui L
mBio; 2020 Feb; 11(1):. PubMed ID: 32098812
[TBL] [Abstract][Full Text] [Related]
7. Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001-2018).
Raman J; Kagoro FM; Mabuza A; Malatje G; Reid A; Frean J; Barnes KI
Malar J; 2019 Aug; 18(1):280. PubMed ID: 31438951
[TBL] [Abstract][Full Text] [Related]
8. Molecular Surveillance of Artemisinin-Based Combination Therapies Resistance in Plasmodium falciparum Parasites from Bioko Island, Equatorial Guinea.
Liu Y; Liang X; Li J; Chen J; Huang H; Zheng Y; He J; Ehapo CS; Eyi UM; Yang P; Lin L; Chen W; Sun G; Liu X; Zha G; Wang J; Wang C; Wei H; Lin M
Microbiol Spectr; 2022 Jun; 10(3):e0041322. PubMed ID: 35670601
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of molecular markers of Plasmodium falciparum artemisinin resistance (kelch13 mutations) in Papua New Guinea between 2016 and 2018.
Lautu-Gumal D; Razook Z; Koleala T; Nate E; McEwen S; Timbi D; Hetzel MW; Lavu E; Tefuarani N; Makita L; Kazura J; Mueller I; Pomat W; Laman M; Robinson LJ; Barry AE
Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():188-193. PubMed ID: 34271323
[TBL] [Abstract][Full Text] [Related]
10. A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa.
Ndwiga L; Kimenyi KM; Wamae K; Osoti V; Akinyi M; Omedo I; Ishengoma DS; Duah-Quashie N; Andagalu B; Ghansah A; Amambua-Ngwa A; Tukwasibwe S; Tessema SK; Karema C; Djimde AA; Dondorp AM; Raman J; Snow RW; Bejon P; Ochola-Oyier LI
Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():155-161. PubMed ID: 34146993
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology and evolution of drug-resistant genes in the malaria parasite Plasmodium falciparum in southwestern Nigeria.
Oboh MA; Singh US; Antony HA; Ndiaye D; Badiane AS; Ali NA; Bharti PK; Das A
Infect Genet Evol; 2018 Dec; 66():222-228. PubMed ID: 30316883
[TBL] [Abstract][Full Text] [Related]
12. Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments-a WWARN individual patient data meta-analysis.
WWARN K13 Genotype-Phenotype Study Group
BMC Med; 2019 Jan; 17(1):1. PubMed ID: 30651111
[TBL] [Abstract][Full Text] [Related]
13. Artemisinin resistance surveillance in African Plasmodium falciparum isolates from imported malaria cases to Italy.
L'Episcopia M; Bartoli TA; Corpolongo A; Mariano A; D'Abramo A; Vulcano A; Paglia MG; Perrotti E; Menegon M; Nicastri E; Severini C
J Travel Med; 2021 Jul; 28(5):. PubMed ID: 33295621
[TBL] [Abstract][Full Text] [Related]
14. Rare mutations in Pfmdr1 gene of Plasmodium falciparum detected in clinical isolates from patients treated with anti-malarial drug in Nigeria.
Idowu AO; Oyibo WA; Bhattacharyya S; Khubbar M; Mendie UE; Bumah VV; Black C; Igietseme J; Azenabor AA
Malar J; 2019 Sep; 18(1):319. PubMed ID: 31533729
[TBL] [Abstract][Full Text] [Related]
15. Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran.
Afsharpad M; Zakeri S; Pirahmadi S; Djadid ND
Acta Trop; 2012 Jan; 121(1):13-8. PubMed ID: 22001304
[TBL] [Abstract][Full Text] [Related]
16. Distribution of Plasmodium falciparum K13 gene polymorphisms across transmission settings in Ghana.
Dieng CC; Morrison V; Donu D; Cui L; Amoah L; Afrane Y; Lo E
BMC Infect Dis; 2023 Nov; 23(1):801. PubMed ID: 37974079
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Plasmodium falciparum Molecular Markers of Antimalarial Drug Resistance in a Residual Malaria Focus Area in Sabah, Malaysia.
Norahmad NA; Mohd Abd Razak MR; Abdullah NR; Sastu UR; Imwong M; Muniandy PK; Saat MN; Muhammad A; Jelip J; Tikuson M; Yusof N; Rundi C; Mudin RN; Syed Mohamed AF
PLoS One; 2016; 11(10):e0165515. PubMed ID: 27788228
[TBL] [Abstract][Full Text] [Related]
18. Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.
Oladipo OO; Wellington OA; Sutherland CJ
Diagn Pathol; 2015 Apr; 10():41. PubMed ID: 25928117
[TBL] [Abstract][Full Text] [Related]
19. Molecular Epidemiology of Plasmodium falciparum kelch13 Mutations in Senegal Determined by Using Targeted Amplicon Deep Sequencing.
Talundzic E; Ndiaye YD; Deme AB; Olsen C; Patel DS; Biliya S; Daniels R; Vannberg FO; Volkman SK; Udhayakumar V; Ndiaye D
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069653
[TBL] [Abstract][Full Text] [Related]
20. Molecular assessment of kelch13 non-synonymous mutations in Plasmodium falciparum isolates from Central African Republic (2017-2019).
Nzoumbou-Boko R; Panté-Wockama CG; Ngoagoni C; Petiot N; Legrand E; Vickos U; Gody JC; Manirakiza A; Ndoua C; Lombart JP; Ménard D
Malar J; 2020 May; 19(1):191. PubMed ID: 32448203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
